Why Nostr? What is Njump?
2025-04-25 07:41:46
in reply to

finance.yahoo.com on Nostr: finance.yahoo.com ✍️ Summit Therapeutics' shares surged 14.7% on Wednesday as the ...



✍️ Summit Therapeutics' shares surged 14.7% on Wednesday as the company announced positive results from its phase III trial for its lung cancer drug, ivonescimab.
👉 Summit Therapeutics' shares surged 14.7% on Wednesday
👉 Positive results from phase III trial for lung cancer drug, ivonescimab
👉 Ivonescimab delivered a statistically significant improvement in patients with NSCLC
👉 Could potentially lead to ivonescimab becoming a blockbuster drug

#BillyDuberstein #health

https://s.yimg.com/ny/api/res/1.2/hHgz.KvXyWSeOvY5iTG.7g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MzM-/https://media.zenfs.com/en/motleyfool.com/55917c323746a1ac555e10c5bfcba981

https://finance.yahoo.com/news/why-summit-therapeutics-rocketed-double-200500961.html

Author Public Key
npub1g8g50xheecekjh2qvhzwvqqycmwfy2kmlnqhv0nfj0qf48dhr0rst3ldht